Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AstraZeneca Signs Deal to Tackle Japan's Drug Lag (Japan)

This article was originally published in PharmAsia News

Executive Summary

Pharmaceutical giant AstraZeneca announced Sept. 26 it had entered a partnership with Tokyo's prestigious Keio University School of Medicine. Currently, there is a significant delay between the time drugs debut in Europe and North American and when they are made available to Japanese patients. By partnering with Keio, AstraZeneca hopes to solve this problem by increasing the number of early clinical trials conducted in Japan. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts